×

Register now for full access to all the content

First Name
Last Name
Company Name
Title
Country
Thank you for registering!
Error - something went wrong!

Parexel Simplifies Access to Knowledge

May 7, 2019
A new report by the Economist Intelligence Unit (EIU) and commissioned by Parexel International Corporation reveals that new innovations in drug development have a positive impact on clinical trial timelines, likelihood of market launch, and inclusion on selected payer formularies.
Previous Video
Assess the Strength of Your Evidence Strategy
Assess the Strength of Your Evidence Strategy

See how the Evidence Wisely Assessment Tool can help you assess your readiness for market access. Generate ...

Next Video
Parexel Analyzes the Real-World Data Revolution and Role of Early Payer Engagement
Parexel Analyzes the Real-World Data Revolution and Role of Early Payer Engagement

Richard Tolley, Vice President Integrated Market Access Solutions at Parexel discusses a recent roundtable ...